ArticleCancer cell2009

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.

Thomas O'Hare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.